Drug intelligence / Profile preview

MultiCal

Development stage: Unknown
Lead developer: Pulpdent
Administration: Topical

Overview

MultiCal is a direct pulp capping agent investigated for its effect on human pulpal response following intentional pulp exposure. In a clinical trial, it was compared to other agents like calcium hydroxide and Mineral Trioxide Aggregate (MTA) to assess its ability to promote dentinal bridge formation and modulate inflammatory reactions in the dental pulp. Its application involves direct placement onto the exposed buccal pulp horn.

Beyond the preview

Go deeper on MultiCal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MultiCal.

Explore the full profile